Variant report
Variant | rs1188482 |
---|---|
Chromosome Location | chr1:228617493-228617494 |
allele | G/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:228617476-228617746 | H1-hESC | embryonic stem cell: | n/a | chr1:228617593-228617604 |
2 | CEBPB | chr1:228617419-228617768 | K562 | blood: | n/a | chr1:228617593-228617604 |
3 | CEBPB | chr1:228617423-228617744 | IMR90 | lung: | n/a | chr1:228617593-228617604 |
4 | CEBPB | chr1:228617431-228617748 | A549 | lung: | n/a | chr1:228617593-228617604 |
5 | CEBPB | chr1:228617424-228617750 | HepG2 | liver: | n/a | chr1:228617593-228617604 |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:228555772..228558767-chr1:228616015..228617716,2 | K562 | blood: | |
2 | chr1:228608216..228614553-chr1:228615725..228619790,7 | MCF-7 | breast: | |
3 | chr1:228615761..228621381-chr1:228643502..228647221,5 | MCF-7 | breast: | |
4 | chr1:228606678..228609464-chr1:228615990..228617964,3 | K562 | blood: | |
5 | chr1:228617056..228620810-chr1:228631528..228634565,4 | MCF-7 | breast: | |
6 | chr1:228616675..228619300-chr1:228638219..228642365,5 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
HIST3H3 | TF binding region |
ENSG00000196890 | Chromatin interaction |
ENSG00000168148 | Chromatin interaction |
ENSG00000181218 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1007686 | 0.89[GIH][hapmap] |
rs10157289 | 0.81[EUR][1000 genomes] |
rs10158354 | 0.81[EUR][1000 genomes] |
rs10158680 | 0.81[EUR][1000 genomes] |
rs10916313 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.89[AFR][1000 genomes];0.98[ASN][1000 genomes] |
rs10916317 | 0.89[GIH][hapmap] |
rs1150917 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1150918 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.92[TSI][hapmap];0.99[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs11581974 | 1.00[CEU][hapmap];0.95[CHB][hapmap];0.81[CHD][hapmap];0.94[GIH][hapmap];0.94[JPT][hapmap];1.00[TSI][hapmap];0.99[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11587839 | 0.98[ASN][1000 genomes] |
rs1188473 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.92[TSI][hapmap];0.99[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1188474 | 0.82[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1188475 | 0.86[EUR][1000 genomes] |
rs1188483 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1188485 | 1.00[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1188487 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1188488 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1188489 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs12031395 | 0.81[EUR][1000 genomes] |
rs12061490 | 0.86[CHB][hapmap];0.88[JPT][hapmap];0.83[TSI][hapmap];0.81[EUR][1000 genomes] |
rs12061642 | 0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs12065660 | 0.81[EUR][1000 genomes] |
rs12065815 | 0.81[EUR][1000 genomes] |
rs12081278 | 0.83[JPT][hapmap] |
rs12082349 | 0.86[EUR][1000 genomes] |
rs12085738 | 0.84[EUR][1000 genomes] |
rs12089997 | 0.81[EUR][1000 genomes] |
rs12093491 | 0.86[EUR][1000 genomes] |
rs12094956 | 1.00[CHB][hapmap];0.89[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.83[TSI][hapmap];0.86[EUR][1000 genomes] |
rs12096217 | 0.82[TSI][hapmap] |
rs12691493 | 0.95[CHB][hapmap];0.89[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.83[TSI][hapmap];0.89[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12725863 | 0.98[ASN][1000 genomes] |
rs12735877 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.86[EUR][1000 genomes] |
rs12751024 | 1.00[MEX][hapmap];0.82[TSI][hapmap] |
rs12760907 | 0.91[CHB][hapmap];1.00[JPT][hapmap];0.86[EUR][1000 genomes] |
rs13373984 | 0.95[CHB][hapmap];0.89[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.83[TSI][hapmap];0.89[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs2230656 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.89[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.92[TSI][hapmap];0.97[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs3105114 | 0.83[EUR][1000 genomes] |
rs34090141 | 0.89[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs34673199 | 0.81[EUR][1000 genomes] |
rs35155240 | 0.81[EUR][1000 genomes] |
rs35711644 | 0.82[EUR][1000 genomes] |
rs3738687 | 0.86[EUR][1000 genomes] |
rs3795785 | 0.88[JPT][hapmap] |
rs3795800 | 0.81[CHB][hapmap];0.83[JPT][hapmap] |
rs3795810 | 0.81[CHB][hapmap];0.83[JPT][hapmap];0.83[TSI][hapmap] |
rs3795811 | 0.86[CHB][hapmap];0.88[JPT][hapmap] |
rs3795814 | 0.81[CHB][hapmap];0.83[JPT][hapmap];0.83[TSI][hapmap];0.81[EUR][1000 genomes] |
rs4581279 | 1.00[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4653551 | 1.00[CHB][hapmap];0.94[CHD][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];0.98[MKK][hapmap];1.00[YRI][hapmap];0.89[AFR][1000 genomes];0.98[ASN][1000 genomes] |
rs4653552 | 0.89[AFR][1000 genomes];0.98[ASN][1000 genomes] |
rs4653960 | 0.92[ASN][1000 genomes] |
rs474600 | 0.95[CHB][hapmap];0.84[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.83[TSI][hapmap];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs493950 | 0.89[GIH][hapmap] |
rs494154 | 0.82[CHB][hapmap] |
rs503203 | 0.88[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs503391 | 0.95[CHB][hapmap];0.86[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.83[TSI][hapmap];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs505129 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.84[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs513467 | 0.94[GIH][hapmap] |
rs532465 | 0.95[CHB][hapmap];0.83[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.83[TSI][hapmap];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs541959 | 0.81[EUR][1000 genomes] |
rs56174824 | 0.86[EUR][1000 genomes] |
rs564309 | 0.95[CHB][hapmap];0.89[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.81[TSI][hapmap];0.89[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs572442 | 0.82[EUR][1000 genomes] |
rs573128 | 0.84[CHB][hapmap];0.86[JPT][hapmap];0.82[EUR][1000 genomes] |
rs58462432 | 0.84[ASN][1000 genomes] |
rs61825312 | 0.81[EUR][1000 genomes] |
rs61825336 | 0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs61825338 | 0.88[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6426501 | 0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6426503 | 0.89[GIH][hapmap] |
rs6659690 | 0.89[AFR][1000 genomes];0.98[ASN][1000 genomes] |
rs6666241 | 0.98[ASN][1000 genomes] |
rs7513530 | 0.99[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7524236 | 1.00[CHB][hapmap];1.00[CHD][hapmap];0.89[GIH][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs7529055 | 0.89[GIH][hapmap] |
rs7555386 | 0.98[ASN][1000 genomes] |
rs9787095 | 0.81[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv32853 | chr1:227880116-228806209 | Enhancers Genic enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Strong transcription Active TSS Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 187 gene(s) | inside rSNPs | diseases |
2 | nsv826908 | chr1:227895386-228691100 | Strong transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 157 gene(s) | inside rSNPs | diseases |
3 | nsv523935 | chr1:228038124-228681749 | Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Weak transcription Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 137 gene(s) | inside rSNPs | diseases |
4 | nsv873255 | chr1:228254753-228684779 | Genic enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 133 gene(s) | inside rSNPs | diseases |
5 | nsv827019 | chr1:228314167-228651020 | Enhancers Weak transcription Genic enhancers Active TSS Flanking Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 106 gene(s) | inside rSNPs | diseases |
6 | nsv873270 | chr1:228442663-228699477 | Flanking Active TSS Weak transcription Strong transcription Enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 66 gene(s) | inside rSNPs | diseases |
7 | nsv1009891 | chr1:228450763-228742676 | Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Bivalent/Poised TSS Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 68 gene(s) | inside rSNPs | diseases |
8 | nsv517545 | chr1:228456147-228685999 | Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 66 gene(s) | inside rSNPs | diseases |
9 | nsv1013500 | chr1:228459134-228849601 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 98 gene(s) | inside rSNPs | diseases |
10 | nsv873279 | chr1:228494790-228681195 | Weak transcription Flanking Bivalent TSS/Enh Strong transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 65 gene(s) | inside rSNPs | diseases |
11 | nsv873281 | chr1:228505739-228656780 | Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 57 gene(s) | inside rSNPs | diseases |
12 | esv1808261 | chr1:228509427-228674518 | Enhancers Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 63 gene(s) | inside rSNPs | diseases |
13 | esv2829948 | chr1:228509427-228687948 | Bivalent/Poised TSS Active TSS Genic enhancers Flanking Active TSS Strong transcription Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 65 gene(s) | inside rSNPs | diseases |
14 | nsv508697 | chr1:228540037-228622614 | Flanking Active TSS Enhancers Weak transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 28 gene(s) | inside rSNPs | diseases |
15 | nsv549296 | chr1:228585837-228720480 | Flanking Active TSS Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 64 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228610600-228620400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:228613000-228621000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr1:228616000-228617600 | Weak transcription | K562 | blood |